Semiconductor Companies Announce Quarterly Financial Results - Research Report on ON Semiconductor, Marvell, Atmel, Intersil, and Cavium
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, August 28, 2013 /PRNewswire/ --
Today, Analysts' Corner announced new research reports highlighting ON Semiconductor Corp. (NASDAQ: ONNN), Marvell Technology Group Ltd. (NASDAQ: MRVL), Atmel Corporation (NASDAQ: ATML), Intersil Corporation (NASDAQ: ISIL), and Cavium, Inc. (NASDAQ: CAVM). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
ON Semiconductor Corp. Research Report
On August 1, 2013, ON Semiconductor Corp. (ON Semiconductor) reported its Q2 FY 2013 (period ended June 28, 2013) financial results. Total revenues declined 7.6% YoY, but grew 4.1% QoQ to $688.3 million. Net income attributable to the Company stood at $47.7 million, or $0.11 per diluted share, compared to $6.9 million or $0.02 in Q2 FY 2012. Keith Jackson, President and CEO of ON Semiconductor, said, "Our design win momentum across our targeted growth segments of wireless communications, automotive and white goods remains strong, and our investments in these end-markets are yielding positive results." He added, "Based upon product booking trends, backlog levels, and estimated turns levels, we anticipate that total ON Semiconductor revenues will be approximately $700 to $730 million in the third quarter of 2013. The outlook for the third quarter of 2013 includes stock-based compensation expense of approximately $8 to $10 million." The Full Research Report on ON Semiconductor Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/513c_ONNN]
Marvell Technology Group Ltd. Research Report
On August 6, 2013, Marvell Technology Group Ltd. (Marvell) announced that China Mobile's first self-branded smartphone, the Android-based M601, is powered by the Marvell ARMADA Mobile PXA988 unified 3G platform, which integrates a powerful processor with a mature and proven cutting-edge cellular modem. According to the Company, its PXA988 platform is designed to deliver high-performance computing with industry-leading graphics capabilities and best-in-class, robust connectivity, enabling a high-performance, cost-effective, Time Division Synchronous Code Division Multiple Access mobile device for China Mobile's 720 million subscribers. Weili Dai, President and Co-founder of Marvell said, "I am very proud of our collaboration with China Mobile and Marvell's investment in developing advanced TD-SCDMA technology. I am very thankful for the innovation, dedication and contributions made by the China Mobile and Marvell global engineering teams." The Full Research Report on Marvell Technology Group Ltd. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/4456_MRVL]
Atmel Corporation Research Report
On July 31, 2013, Atmel Corporation (Atmel) released its Q2 2013 financial results. Net revenues were down 5.5% YoY and up 5.7% QoQ to $347.8 million. On a GAAP basis, the Company's reported net income was $13 million, compared to net income of approximately $0.8 million in Q2 2012, and compared to a net loss of $47.7 million or $0.11 per diluted share in Q1 2013. Steve Laub, Atmel's President and CEO, commented, "We are pleased with the progress we made on improving our gross margin and remain focused on achieving our long-term operating model goals." The Full Research Report on Atmel Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/3d14_ATML]
Intersil Corporation Research Report
On July 30, 2013, Intersil Corporation (Intersil) released its financial results for Q2 FY 2013 (period ending July 5, 2013). Revenues were down 11.1% YoY and up 10.0% QoQ to $144.8 million. Gross margin stood at 55.2% compared to 54.5% in Q2 FY 2012. Net income was $1.0 million, or $0.01 per diluted share, compared to a net loss of $14.5 million or $0.11 per diluted share in Q2 FY 2012. Additionally, Intersil provided its guidance for Q3 FY 2013 (period ending October 4, 2013), with GAAP revenue expected in the range of $146 million to $152 million, and a loss per share in $0.03 to $0.01 range. The Full Research Report on Intersil Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/bfbb_ISIL]
Cavium, Inc. Research Report
On July 31, 2013, Cavium, Inc. (Cavium) released its Q2 2013 financial results. The Company's net revenue increased 6.7% QoQ to $74.2 million. On a GAAP basis, net loss attributable to the Company was $4.3 million or $0.08 per diluted share, compared to $3.2 million or $0.06 per diluted share in Q1 2013. The Company's GAAP gross margins were 58.3% compared to 62.4% in Q1 2013. As per non-GAAP results, the Company reported a Q2 2013 net income of $12.6 million or $0.23 per diluted share, compared to net income of $10.2 million or $0.19 per diluted share in Q1 2013. Non-GAAP gross margins were 65.8% compared to 65.4% in Q1 2013, and non-GAAP operating margins were 18.7% compared to 16.0% in Q1 2013. The Full Research Report on Cavium, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/6c55_CAVM]
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE Analysts' Corner
More by this Source
Global Cell Therapy - Technologies, Markets and Companies
Jan 16, 2014, 14:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.